Company: DRTSW
Filing Date: 2025-06-17
Form Type: 6-K
Source: 0001213900-25-055181
Chunk: 1

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-17
Form: 6-K
Chunk 1
---
er, registered public accounting firm, a member of Ernst & Young Global, as the Company’s independent registered public      
 accounting firm for the year ending December 31, 2025 and until the Company’s next annual general meeting of shareholders, and     
 to authorize the Company’s board of directors (with power of delegation to its audit committee) to set the fees to be paid to such 
 auditors; and                                                                                                                      |

| (4) | to approve and ratify an amendment to the Company’s 
 Non-Employee Director Compensation Package.         |

All proposals were approved at the Meeting by
the respective requisite majorities in accordance with the Companies Law, and the Company’s Amended and Restated Articles of Association,
as described in the Proxy Statement which was attached as Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form
6-K, furnished to the Securities and Exchange Commission on May 13, 2025.

This Form 6-K is incorporated by reference into
the Company’s registration statements on Form F-3 (File Nos. 333-271073,
333-264306 and 333-274457)
and Form S-8 (File Nos. 333-264169 333-270406, 333-277733 and 333-285745).

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

| Date: June 17, 2025 | Alpha Tau Medical Ltd. 
 By:                    | /s/ Uzi Sofer           |
|:--------------------|:-----------------------|:------------------------|
|                     |                        | Uzi Sofer               |
|                     |                        | Chief Executive Officer |

<div align='center'>2</div>